home / stock / bmra / bmra quote
Last: | $0.3326 |
---|---|
Change Percent: | -5.76% |
Open: | $0.349 |
Close: | $0.3326 |
High: | $0.349 |
Low: | $0.325 |
Volume: | 24,556 |
Last Trade Date Time: | 07/19/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$0.3326 | $0.349 | $0.3326 | $0.349 | $0.325 | 24,556 | 07-19-2024 |
$0.33 | $0.3586 | $0.33 | $0.375 | $0.33 | 46,328 | 07-18-2024 |
$0.3694 | $0.36 | $0.3694 | $0.3853 | $0.355 | 64,421 | 07-17-2024 |
$0.3601 | $0.379 | $0.3601 | $0.379 | $0.3601 | 37,761 | 07-16-2024 |
$0.3579 | $0.356 | $0.3579 | $0.37 | $0.3552 | 55,868 | 07-15-2024 |
$0.3569 | $0.3669 | $0.3569 | $0.379 | $0.35 | 62,590 | 07-12-2024 |
$0.367 | $0.4168 | $0.367 | $0.4281 | $0.28 | 237,667 | 07-11-2024 |
$0.4169 | $0.4281 | $0.4169 | $0.4299 | $0.415 | 52,661 | 07-10-2024 |
$0.4282 | $0.451 | $0.4282 | $0.4599 | $0.4134 | 80,578 | 07-09-2024 |
$0.4414 | $0.44 | $0.4414 | $0.47 | $0.4398 | 83,715 | 07-08-2024 |
$0.436 | $0.445 | $0.436 | $0.47 | $0.4321 | 30,874 | 07-05-2024 |
$0.4487 | $0.436 | $0.44865 | $0.4646 | $0.436 | 51,555 | 07-04-2024 |
$0.44865 | $0.436 | $0.44865 | $0.4646 | $0.436 | 51,555 | 07-03-2024 |
$0.445 | $0.44 | $0.445 | $0.464 | $0.44 | 24,319 | 07-02-2024 |
$0.4401 | $0.4334 | $0.4401 | $0.4696 | $0.4328 | 86,755 | 07-01-2024 |
$0.4398 | $0.442 | $0.4398 | $0.47 | $0.4307 | 50,056 | 06-28-2024 |
$0.4495 | $0.446 | $0.4495 | $0.469 | $0.42 | 67,492 | 06-27-2024 |
$0.454 | $0.43 | $0.454 | $0.4748 | $0.4255 | 163,807 | 06-26-2024 |
$0.4249 | $0.42 | $0.4249 | $0.5 | $0.42 | 169,469 | 06-25-2024 |
$0.4186 | $0.445 | $0.4186 | $0.51 | $0.4186 | 164,294 | 06-24-2024 |
News, Short Squeeze, Breakout and More Instantly...
inFoods ® IBS patients can now conveniently self-collect a blood sample using a simple finger-stick methodology in the privacy of their home inFoods ® IBS test is the first of its kind to identify specific foods that can trigger an Irritable Bowel Syndrome (I...
Biomerica (NASDAQ: BMRA) , a biomedical technology company that develops, patents, manufactures and markets advanced diagnostics and therapeutic products, has entered into an at-market issuance sales agreement with EF Hutton LLC and R.F. Lafferty & Co. Inc. According to the company, the agree...
With IBS affecting 10 to 15% of the global population, the associated $21 billion in direct medical costs and absenteeism underscores the urgent need of innovative solutions. Recognized as the 7th most common diagnosis by all physicians, IBS represents a significant healthcare burden. inF...